Find Grants

Search results

• Evaluating the EVO treatment optimized for resource constraints: Elements Vital to treat Obesity

  Pfammatter, A. F., Siddique, J. & Spring, B.

  National Institute of Diabetes and Digestive and Kidney Diseases

  7/15/20 → 6/30/25

  Project: Research project

• ProNET: Psychosis-Risk Outcomes Network

  Mittal, V. A. & Shankman, S. A.

  Yale University, National Institute of Mental Health

  9/8/20 → 6/30/25

  Project: Research project

• Histone chaperone networks for new and evicted histones

  Foltz, D. R. & Ben-Sahra, I.

  National Institute of General Medical Sciences

  8/1/21 → 6/30/25

  Project: Research project

• Photogenerated Multi-Spin Systems as Qubits for Quantum Information Science

  Wasielewski, M. R.

  National Science Foundation

  7/1/22 → 6/30/25

  Project: Research project

• Neutralizing the effects of aging to enhance brain cancer immunotherapy

  Wainwright, D. A.

  American Cancer Society

  7/1/21 → 6/30/25

  Project: Research project

• Prot #11899.A (MIND): A Prospective, Multicenter Study of Artemis a Minimally Invasive Neuro Evacuation Device, in the Removal of Intracerebral Hemorrhage

  Jahromi, B. S.

  Penumbra, Inc.

  7/3/19 → 7/3/25

  Project: Research project

• Prot: PRV-PD101- A Phase 1/2a Study to Evaluate the Safety of PR001A in Patients with Parkinson’s Disease with at Least One GBA1 Mutation

  Simuni, T.

  PPD Investigator Services, LLC, Prevail Therapeutics, Inc.

  7/5/19 → 7/5/25

  Project: Research project

• Prot #92742246: FRONTIER STUDY: A Feasibility Study to Evaluate the Safety of the TheraSphereTM Glioblastoma (GBM) Device in Patients with Recurrent GBM

  Mouli, S. K.

  Boston Scientific Corporation

  7/13/22 → 7/13/25

  Project: Research project

• Reasoning for Social Autonomous Agents

  Forbus, K. D. & Hinrichs, T. R.

  Air Force Office of Scientific Research

  7/15/20 → 7/14/25

  Project: Research project

• Prot #CT-155-C-002: A Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of Treatment with CT-155 in People with Schizophrenia Experiencing Negative Symptoms

  Meltzer, H. Y.

  ICON Clinical Research, LLC, Click Therapeutics, Inc.

  7/14/22 → 7/14/25

  Project: Research project

• Northwestern University Echo Core Lab (NUECL) for the multi-center study titled GOAL-HF

  Shah, S. J.

  AnaCardio AB

  7/18/22 → 7/18/25

  Project: Research project

• Prot #CM-101-PSC-101: A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial Evaluating the Safety and Efficacy of CM-101 in Subjects with Primary Sclerosing Cholangitis - The Spring Study

  Boike, J. R.

  Covance Inc., Chemomab Therapeutics Ltd.

  7/19/22 → 7/19/25

  Project: Research project

• Validity Evidence on the Spatial Ability Assessment for STEM Instruction and Evaluation

  Uttal, D. H.

  University of Alabama, Institute of Education Sciences

  1/1/22 → 7/20/25

  Project: Research project

• Entac-PrevisEA-001 - A Minimal-Risk, Multi-Center, Prospective, Clinical Trial to Evaluate the PrevisEA Device for Predicting Gastrointestinal Impairment

  Poylin, V.

  Clinical Research Strategies, LLC, Entac Medical, Inc.

  7/21/22 → 7/21/25

  Project: Research project

• Prot #19-188: NU DF21B07: Evaluation of Talazoparib, a PARP Inhibitor, in Patients with Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

  Shah, A. N.

  Dana-Farber/Partners CancerCare, Inc., Pfizer Inc.

  7/22/22 → 7/22/25

  Project: Research project

• Protocol 402-C-1808: A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease

  Tuazon, J. A.

  Reata Pharmaceuticals, Inc.

  7/24/19 → 7/24/25

  Project: Research project

• Prot #NOX66-004 / 263538: A Dose Escalation and Dose Expansion Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients with Soft Tissue Sarcoma - CEP-2

  Pollack, S. M.

  Parexel, Noxopharm Limited

  7/25/22 → 7/25/25

  Project: Research project

• Prot#B3461045: A Phase 3 Multicenter, Open-Label Study to Evaluate the Safety of Daily Oral Dosing of Tafamidis Meglumine (PF-06291826-83) 20 mg or 80 mg (or Tafamidis(06291826-00) 61 mg) in Subjects Diagnosed With Transthyretin Cardiomyopathy (TTR-CM)

  Shah, S. J.

  PPD Investigator Services, LLC, Pfizer Inc.

  7/27/16 → 7/27/25

  Project: Research project

• Prot#ISI-ION-R02: A Multicenter Retrospective Review to Evaluate the Feasibility of Dye Marking Using the Ion Endoluminal System

  Kim, S. S. & Bharat, A.

  Intuitive Surgical Operations, Inc.

  7/29/22 → 7/29/25

  Project: Research project

• NWU20-04-01 Roswell Park-Per Case Reimbursable

  Khan, S. A.

  National Cancer Institute

  9/3/19 → 7/31/25

  Project: Research project

• Core B Barrier Damage and The Immune Cascade: Northwestern University CounterACT Center of Excellence (NUCCX)

  Dravid, V. P. & Thaxton, C. S.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  9/17/21 → 7/31/25

  Project: Research project

• Abbass NU-Cost Reimbursable

  Abbass, M. A.

  National Cancer Institute

  9/3/19 → 7/31/25

  Project: Research project

• Glycemic Profiles and Pregnancy Outcomes Study (GLOSS)

  Lowe Jr, W. L., Yee, L. M., Aleppo, G., Szmuilowicz, E. D. & Yee, L. M.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/20/19 → 7/31/25

  Project: Research project

• Quantifying the Prevalence and Phenotypic Consequences of Transcriptional Irreversibility in Bacteria

  Motter, A. E.

  University of Texas Southwestern Medical School, National Science Foundation

  8/15/22 → 7/31/25

  Project: Research project

• Yittrium-90 radiation lobectomy: Dose optimization and prediction of FLR hypertrophy to enable resection of HCC

  Collins, J. D., Lewandowski, R. J., Caicedo, J. C., Katariya, N. N., Kulik, L. M., Markl, M., Miller, F. H., Pezhouh, M. K. & Ragin, A.

  National Cancer Institute

  8/1/19 → 7/31/25

  Project: Research project